Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: Application of plasma biomarkers
- 1 January 2007
- journal article
- review article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 42 (1), 2-10
- https://doi.org/10.1080/00365520600863720
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Long term follow up of patients treated for Helicobacter pylori infectionGut, 2005
- Age-Dependent Accuracy of Helicobacter pylori Antibody Assays for Adults, with Special Emphasis on Atrophic GastritisClinical and Vaccine Immunology, 2004
- Improvement in serum pepsinogens and gastrin in long‐term monitoring after eradication of Helicobacter pylori: comparison with H. pylori‐negative patientsAlimentary Pharmacology & Therapeutics, 2004
- Influence of anti-ulcer drugs used in Japan on the result of 13 C-urea breath test for the diagnosis of Helicobacter pylori infectionThe Esophagus, 2003
- Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspepticsBritish Journal of Cancer, 2003
- Serum pepsinogen concentration as a marker of Helicobacter pylori infection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levelsThe Esophagus, 2003
- Atrophic Gastritis Serum Levels of Amidated Gastrin-17 and Pepsinogen I in Atrophic Gastritis: An Observational Case-Control StudyScandinavian Journal of Gastroenterology, 2002
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001
- Atrophic gastritis during long‐term omeprazole therapy affects serum vitamin B12 levelsAlimentary Pharmacology & Therapeutics, 1999
- Circulating Anti-Helicobacter pylori Immunoglobulin A Antibodies and Low Serum Pepsinogen I Level Are Associated with Increased Risk of Gastric CancerAmerican Journal of Epidemiology, 1996